Relation Therapeutics at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

Relation Therapeutics takes part in 3 sessions at FoG London 2027 in London, its home city. Its sessions cover the datasets behind its AI and deep learning models and new methods for spatial RNA profiling. Concrete topics include spatial total RNA profiling through in situ polyadenylation and how to choose between short- and long-read sequencing.

OrganizationFoG London 2027 Attendance
Biotech
Drug discovery company combining single-cell and functional genomics data from patient tissue with machine learning to find drug targets.
Talk
Wed Jan 27
11:30–12:00
Relation's AI & Deep Learning Platform: What datasets the ML models are trained on
What biological and genomic datasets train deep learning models for drug discovery, and how data quality and diversity shape their performance.
Talk
Wed Jan 27
12:30–13:00
Spatial Total RNA Profiling via in situ Polyadenylation
How a new method maps all of each cell's RNA in tissue, revealing splicing and non-coding RNA even in wax-preserved clinical samples.
Panel
Wed Jan 27
17:30–18:00
Choosing the Right Sequencing Technology: Short Reads, Long Reads & Beyond
How researchers weigh short-read and long-read sequencing on accuracy, resolution, throughput and cost, and when to combine them.
with Wellcome Sanger Institute, AstraZeneca
Also
Presenting at the meeting, beyond the sessions above

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Relation Therapeutics

Tell us what you sell and we’ll find the people at Relation Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction